MYD88 Mutation Analysis
Test Catalog Information
| Test Catalog Synonyms | |
| EPIC Synonyms | |
| Cerner Primary Mnemonic | zzMYD88 Mutation Analysis |
| EPIC Display Name | MYD88 Mutation Analysis |
| Allscripts (AEHR) Order Name | MYD88 Mutation Analysis |
| Sunrise Clinical Manager (SCM) Order Name | MYD88, Mutation Analysis |
| EPIC Inpatient Orderable | No |
| EPIC Outpatient Orderable | No |
| Cerner Results | |
| Clinical Info |
L265P mutation in the MYD88 gene is found in approximately 90% of WaldenstrÖm macroglobulinemia and IgM-expressing lymphoplasmacytic lymphoma (LPL). There is a low incidence of L265P MYD88 mutation in other systemic CD5-negative B-cell lymphoproliferative disorders including atypical chronic lymphocytic leukemia, nodal marginal zone lymphoma (MZL), splenic MZL and mucosa-associated lymphoid tissue (MALT)-type MZL. |
| Specimen Type |
Blood, Bone Marrow |
| Container |
Lavender Top Tube |
| Collection Instructions |
Specimen: 5 mL whole blood in EDTA lavender top (2mL min) or 2 mL Bone Marrow in EDTA Lavender top ( 0.5 mL min) |
| Transport Instructions | |
| Specimen Stability |
Room temperature: 7 Days Refrigerated: 7 Days Frozen: Unacceptable |
| Methodology |
Next Generation Sequencing |
| Days Performed |
TAT: 6 Days |
| Performing Laboratory |
Quest Diagnostics Nichols Institute |
| CPT |
81305 Loinc code; Pending assignment |
| PDM |
225202 |
Desired Epic Build MYD88 Mutation Analysis
| Cerner Primary Mnemonic: | zzMYD88 Mutation Analysis |
| PDM | 225202 |
| Informatics - Workgroup | Molecular-send outs |
| Synonyms * | |
| Display Name * | MYD88 Mutation Analysis |
| Order Entry Specimen Sources * | |
| Order Entry Specimen Types |
Aspirate
|
| Specimen Navigator Specimen Types | |
| Specimen Navigator Specimen Sources | |
| Specimen Navigator Short Name | |
| Ordering info (EPIC SmartText) | L265P mutation in the MYD88 gene is found in approximately 90% of WaldenstrÖm macroglobulinemia and IgM-expressing lymphoplasmacytic lymphoma (LPL). There is a low incidence of L265P MYD88 mutation in other systemic CD5-negative B-cell lymphoproliferative disorders including atypical chronic lymphocytic leukemia, nodal marginal zone lymphoma (MZL), splenic MZL and mucosa-associated lymphoid tissue (MALT)-type MZL. |
| IP Orderable | No |
| OP Orderable | No |
|
AOEs * | |
| AP AOEs | |
| Special History | No |
| Build Comments | |
| Filter * | genetics |
| Procedure Category Change | |
| Cerner Results | |
Current Actual EPIC Build as of 10/28/2024
| Procedure Id | 115541 | ||||||||||||
| Pdm | 225202 | ||||||||||||
| Order Display Name | MYD88 Mutation Analysis | ||||||||||||
| Procedure Name | MYD88, MUTATION ANALYSIS | ||||||||||||
| Procedure Master Number | LAB11613 | ||||||||||||
| Short Procedure Name | MYD88, MUTATION ANALYSIS | ||||||||||||
| Category Code | 15.0 | ||||||||||||
| Category Code Record Name | LAB CYTOGENETICS ORDERABLES | ||||||||||||
| Synonyms | |||||||||||||
| Clinically Active | No | ||||||||||||
| Orderable | No | ||||||||||||
| Performable | No | ||||||||||||
| Filter Genomics | Generic Genomics Procedure | ||||||||||||
| Reference Link Url | https://labs.northwell.edu/epic/test/115541 | ||||||||||||
| Ordering Instructions | |||||||||||||
| Default Specimen Type | Blood | ||||||||||||
| Specimen Type Pick List | Bone Marrow Blood | ||||||||||||
| Specimen Type List | |||||||||||||
| Op Specimen Type List | |||||||||||||
| Specimen Source Pick List | Bone Marrow Aspirate Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||
| Specimen Source Default - Male | |||||||||||||
| Specimen Source Default - Female | |||||||||||||
| Specimen Source List | |||||||||||||
| Op Specimen Source List | |||||||||||||
| Ip Lab Test Components For Report | |||||||||||||
| Op Lab Test Components For Report | |||||||||||||
| Order Questions | ["3048500000"] | ||||||||||||
| Order Questions Record Name | |||||||||||||
| Inpatient Order Questions | ["3048500000"] | ||||||||||||
| Inpatient Order Questions Record Name | |||||||||||||
| Order Specific Question Override | |||||||||||||
| Inpatient Question Override | |||||||||||||
| Location Restrict List Ip | |||||||||||||
| Location Restrict List Ip Record Name | |||||||||||||
| Location Restrict List Include Ip | |||||||||||||
| Location Restrict List Op | |||||||||||||
| Location Restrict List Op Record Name | |||||||||||||
| Location Restrict List Includes Op | |||||||||||||
| Edp Amb Order Specific Questions Record Name | NH IP PATIENT COMPLETED CONSENT | ||||||||||||
| Edp Ip Order Specific Questions Record Name | NH IP PATIENT COMPLETED CONSENT | ||||||||||||
| Edp Ip Specimen Source | |||||||||||||
| Edp Op Specimen Source | |||||||||||||
| Edp Ip Specimen Type | |||||||||||||
| Edp Op Specimen Type | |||||||||||||
| Derived Edp Ip Buttons S | |||||||||||||
| Derived Edp Ip Buttons T | |||||||||||||
| Derived Edp Op Buttons S | |||||||||||||
| Derived Edp Op Buttons T | |||||||||||||
| Ip Orderable | 0 | ||||||||||||
| Op Orderable | 0 | ||||||||||||
EPIC OP AOEs
| |||||||||||||
EPIC IP AOEs
| |||||||||||||
| EPIC Components (results) | |||||||||||||